BH RCM Company — How to Evaluate Behavioral Health Revenue Cycle Firms 2026

BH RCM Company — 2026 Evaluation Framework

Choosing the right BH RCM company (vs general medical RCM) can be a $500K-$2M/yr revenue-impact decision. Specialty focus matters — BH billing has ~30% more denial categories than med/surg.

Why Specialty BH RCM Beats General RCM

  • MHPAEA parity appeal capability — general firms don’t touch this; BH-specialty firms recover 12-18% of BH commercial denials
  • ABA-specific 97153/97155 workflow — supervision-hour docs, BCBA credentialing, retro-billing
  • SUD residential (ASAM 3.7/3.5) appeals — stay-length denial recovery
  • CCBHC PPS reconciliation — encounter tracking + PPS-1/PPS-2 rules per state
  • Telepsychiatry modifier 95/93 — post-PHE payer alignment expertise

5 Questions to Ask Every BH RCM Company

  1. What % of your book is BH/ABA/SUD specialty vs general medical?
  2. Show me 2 case studies at my revenue scale — with denial-rate before/after
  3. How do you handle MHPAEA parity appeals? What’s your recovery rate?
  4. What’s your pricing model + contract length? (4-8% M2M is market)
  5. Onboarding timeline? (Under 30 days for specialty)

Case Study — Revenant Care

12-site BH $70M rev. Denial rate 12.3% → 5.7%. MHPAEA parity $184K. $1.04M cash recovered in 90 days. Full case study.

Free 30-day BH RCM audit · Pricing 4-8%

– KD, Revenant Care